However, there is an increasing trend in AmB-resistant isolates of A. fumigatus [ 11 , 12 ]; hence, the use of fixed-dose combination products can be a useful approach to overcome this challenge [ 13 , 14 , 15 ].
← all excerpts
Co-Delivery of a High Dose of Amphotericin B and Itraconazole by Means of a Dry Powder Inhaler Formulation for the Treatment of Severe Fungal Pulmonary Infections.
1
—
—